Where does Luminary Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Luminary Therapeutics's 6 recorded funding rounds.

Premier Alternatives

Luminary Therapeutics

Minneapolis, MN · Founded 2019 · Privately Held (backing)

Developer a cell therapy platform designed for cancer and autoimmune diseases. Luminary Therapeutics is based in Minneapolis, MN and was founded in 2019. Its last reported valuation was $59 million in Apr 2025. It has raised $24.2 million across 6 recorded rounds; the latest was a $1.4 million seed round in Oct 2025.

Last reported valuation

$59.0M

Oct 2026

Priced at

—

Total raised

$24.2M

Last round

Seed Round

Oct 2025

Cap table — not yet on record

Luminary Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Luminary Therapeutics with a free account

·Watch Luminary Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Luminary Therapeutics

Where does Luminary Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Luminary Therapeutics's 6 recorded funding rounds.